NEXT ONCOLOGY Trademark

Trademark Overview


On Wednesday, March 7, 2018, a trademark application was filed for NEXT ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the NEXT ONCOLOGY trademark a serial number of 87823309. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, November 5, 2024. This trademark is owned by New Experimental Therapeutics of San Antonio, LLC. The NEXT ONCOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting Phase 1 clinical trials for others in the fields of cancer and pharmacology; providing a website for consulting and management in the field of Phase 1 clinical trials, namely, management and compilation of internet-based databases in the field of Phase 1 clinical trials for medical research purposes
next oncology

General Information


Serial Number87823309
Word MarkNEXT ONCOLOGY
Filing DateWednesday, March 7, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, November 5, 2024
Registration Number5682042
Registration DateTuesday, February 19, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 16, 2018

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized word "next" wherein the lines intersecting to form the "x" also form an outline of a person's legs and raised arms with a circle above the "x" as the head and the word "ONCOLOGY" centered below "next" with the right leg of the "x"extending downward to the right of the word "ONCOLOGY".
Goods and ServicesMedical and scientific research, namely, conducting Phase 1 clinical trials for others in the fields of cancer and pharmacology; providing a website for consulting and management in the field of Phase 1 clinical trials, namely, management and compilation of internet-based databases in the field of Phase 1 clinical trials for medical research purposes
NOT AVAILABLE"ONCOLOGY"

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 13, 2018
Primary Code042
First Use Anywhere DateMonday, March 5, 2018
First Use In Commerce DateMonday, March 5, 2018

Trademark Owner History


Party NameNew Experimental Therapeutics of San Antonio, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSan Antonio, TX 78212

Party NameNew Experimental Therapeutics of San Antonio, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Antonio, TX 78212

Party NameNew Experimental Therapeutics of San Antonio, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Antonio, TX 78212

Trademark Events


Event DateEvent Description
Saturday, March 10, 2018NEW APPLICATION ENTERED
Tuesday, March 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 14, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, May 26, 2018ASSIGNED TO EXAMINER
Wednesday, May 30, 2018NON-FINAL ACTION WRITTEN
Wednesday, May 30, 2018NON-FINAL ACTION E-MAILED
Wednesday, May 30, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 27, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 27, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 28, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 12, 2018ASSIGNED TO LIE
Wednesday, September 26, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 16, 2018PUBLISHED FOR OPPOSITION
Tuesday, October 16, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 11, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 11, 2018TEAS STATEMENT OF USE RECEIVED
Saturday, January 12, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 11, 2018USE AMENDMENT FILED
Sunday, January 13, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 16, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 17, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 19, 2019REGISTERED-PRINCIPAL REGISTER
Friday, June 21, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 21, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 19, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, May 16, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 5, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 5, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, November 5, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, December 8, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 8, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 8, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 8, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 8, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED